09.02.2013 Views

2009 Form 990-PF - Bill & Melinda Gates Foundation

2009 Form 990-PF - Bill & Melinda Gates Foundation

2009 Form 990-PF - Bill & Melinda Gates Foundation

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

BILL & MELINDA GATES FOUNDATION 56-2618866<br />

FORM <strong>990</strong><strong>PF</strong>, PART XV - GRANTS AND CONTRIBUTIONS PAID DURING THE YEAR<br />

RELATIONSHIP TO SUBSTANTIAL CONTRIBUTOR<br />

AND<br />

ATTACHMENT 18 (CONT'D)<br />

RECIPIENT NAME AND ADDRESS FOUNDATION STATUS OF RECIPIENT PURPOSE OF GRANT OR CONTRIBUTION AMOUNT<br />

INTERNATIONAL VACCINE INSTITUTE NONE CECIL CZERKINSKY OF THE INTERNATIONAL VACCINE<br />

100,000.<br />

SAN 4-8 BONGCHEON 7-DONG KWANAK-GU 151818 509(A)(1)<br />

SEOUL<br />

KOREA, REPUBLIC OF (SOUTH)<br />

INSTITUTE IN KOREA WILL TEST THE EFFICACY OF<br />

ADMINISTERING TWO APPROVED VACCINES<br />

SUBLINGUALLY - DIRECTLY UNDER THE TONGUE. THE<br />

TEAM WILL ATTEMPT TO PRODUCE NOT ONLY ANTIBODY<br />

RESPONSES BUT ALSO CYTOTOXIC T CELL RESPONSES<br />

IN DISTANT MUCOSAL ORGANS SUCH AS THE LUNGS<br />

AND REPRODUCTIVE TRACT. SUBLINGUAL VACCINE<br />

ADMINISTRATION COULD HELP IMPROVE VACCINE<br />

DELIVERY, COMPLIANCE, AND ENHANCE IMMUNITY<br />

AGAINST A VARIETY OF PATHOGENS.<br />

INTERNATIONAL VACCINE INSTITUTE NONE TO FUND EFFECTIVE AND AFFORDABLE DENGUE<br />

10,500,000.<br />

SAN 4-8 BONGCHEON 7-DONG KWANAK-GU 151818 509(A)(1)<br />

SEOUL<br />

KOREA, REPUBLIC OF (SOUTH)<br />

VACCINES FOR CHILDREN IN DENGUE-ENDEMIC AREAS<br />

INTERNATIONAL VACCINE INSTITUTE NONE TO ACCELERATE THE INTRODUCTION OF CHOLERA<br />

4,564,224.<br />

SAN 4-8 BONGCHEON 7-DONG KWANAK-GU 151818 509(A)(1)<br />

SEOUL<br />

KOREA, REPUBLIC OF (SOUTH)<br />

VACCINES IN ENDEMIC COUNTRIES AND EVALUATE<br />

THEIR USE FOR THE PREVENTION AND CONTROL OF<br />

EPIDEMICS<br />

INTERNATIONAL VACCINE INSTITUTE NONE TO REDUCE THE BURDEN OF CHOLERA IN ENDEMIC AND<br />

2,877,242.<br />

SAN 4-8 BONGCHEON 7-DONG KWANAK-GU 151818 509(A)(1)<br />

SEOUL<br />

KOREA, REPUBLIC OF (SOUTH)<br />

EPIDEMIC SETTINGS WITH THE USE OF A SINGLE<br />

DOSE REGIMEN OF THE KILLED ORAL CHOLERA<br />

VACCINE DEVELOPED BY IVI AND RECENTLY LICENSED<br />

IN INDIA BY SHANTHA BIOTECHNICS<br />

INTERNATIONAL VACCINE INSTITUTE NONE TO SUPPORT THE POLICYMAKERS' MEETING ON THE<br />

46,952.<br />

SAN 4-8 BONGCHEON 7-DONG KWANAK-GU 151818 509(A)(1)<br />

SEOUL<br />

KOREA, REPUBLIC OF (SOUTH)<br />

FOR PUBLIC DISCLOSURE<br />

119 OF 519<br />

INTRODUCTION OF CHOLERA VACCINATION USING<br />

NEW-GENERATION ORAL VACCINES IN INDIA<br />

ATTACHMENT 18

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!